Publications by authors named "Matti Lehtinen"

164Publications

Determinants of Human Papillomavirus Vaccine Uptake by Adult Women Attending Cervical Cancer Screening in 9 European Countries.

Authors:
Claudia Robles Laia Bruni Amelia Acera Joan Carles Riera Laia Prats Mario Poljak Jana Mlakar Anja Oštrbenk Valenčak Tiina Eriksson Matti Lehtinen Karolina Louvanto Maria Hortlund Joakim Dillner Mette T Faber Christian Munk Susanne K Kjaer Karl Ulrich Petry Agnieszka Denecke Lan Xu Marc Arbyn Louise Cadman Jack Cuzick Véronique Dalstein Christine Clavel Silvia de Sanjosé F Xavier Bosch

Am J Prev Med 2020 Dec 24. Epub 2020 Dec 24.

Cancer Epidemiology Research Programme, IDIBELL, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Barcelona, Spain; Faculty of Health Sciences, Universitat Oberta de Catalunya (UOC), Barcelona, Spain.

View Article and Find Full Text PDF
December 2020

Sustained Cross-Reactive Antibody Responses After Human Papillomavirus Vaccinations: Up To 12 Years Follow-Up In The Finnish Maternity Cohort.

Authors:
Hanna Kann Matti Lehtinen Tiina Eriksson Heljä-Marja Surcel Joakim Dillner Helena Faust

J Infect Dis 2020 Oct 3. Epub 2020 Oct 3.

Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.

View Article and Find Full Text PDF
October 2020

Efficacy of AS04-adjuvanted HPV-16/18 vaccine against clearance of incident HPV infections: Pooled analysis of data from the CVT and PATRICIA randomized trials.

Authors:
Joseph E Tota Frank Struyf Allan Hildesheim Paula Gonzalez Martin Ryser Rolando Herrero John Schussler Naveen Karkada Ana Cecilia Rodriguez Nicolas Folschweiller Carolina Porras Mark Schiffman John T Schiller Wim Quint Aimée R Kreimer Matti Lehtinen Cosette M Wheeler Joshua N Sampson

J Infect Dis 2020 Sep 5. Epub 2020 Sep 5.

Divison of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.

View Article and Find Full Text PDF
September 2020

The Age-Specific Cervical Cancer Incidence Differs Between Human Papillomavirus Types: Implications for Predicting the Impact of Elimination Programs.

Authors:
Simopekka Vänskä Tapio Luostarinen Camilla Lagheden Carina Eklund Sara Nordqvist Kleppe Bengt Andrae Pär Sparén Karin Sundström Matti Lehtinen Joakim Dillner

Am J Epidemiol 2020 Jul 8. Epub 2020 Jul 8.

Karolinska University Laboratory, Karolinska University Hospital, Stockholm, Sweden.

View Article and Find Full Text PDF
July 2020

Long-term follow-up of human papillomavirus type replacement among young pregnant Finnish females before and after a community-randomised HPV vaccination trial with moderate coverage.

Authors:
Penelope Gray Hanna Kann Ville N Pimenoff Indira Adhikari Tiina Eriksson Heljä-Marja Surcel Simopekka Vänskä Joakim Dillner Helena Faust Matti Lehtinen

Int J Cancer 2020 Dec 7;147(12):3511-3522. Epub 2020 Jul 7.

Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.

View Article and Find Full Text PDF
December 2020

Impact of HPV vaccination on cervical screening performance: a population-based cohort study.

Authors:
Jiayao Lei Alexander Ploner Matti Lehtinen Pär Sparén Joakim Dillner K Miriam Elfström

Br J Cancer 2020 Jul 4;123(1):155-160. Epub 2020 May 4.

Department of Laboratory Medicine, Karolinska Institutet, SE-141 83, Stockholm, Sweden.

View Article and Find Full Text PDF
July 2020

Age-specific vaccination coverage estimates for influenza, human papillomavirus and measles containing vaccines from seven population-based healthcare databases from four EU countries - The ADVANCE project.

Authors:
Toon Braeye Hanne-Dorthe Emborg Ana Llorente-García Consuelo Huerta Elisa Martín-Merino Talita Duarte-Salles Giorgia Danieli Lara Tramontan Daniel Weibel Chris McGee Marco Villa Rosa Gini Matti Lehtinen Lina Titievsky Miriam Sturkenboom

Vaccine 2020 04 12;38(16):3243-3254. Epub 2020 Mar 12.

P95, Heverlee, Belgium; VACCINE.GRID, Basel, Switzerland; University Medical Center Utrecht, Julius Global Health, Utrecht, The Netherlands.

View Article and Find Full Text PDF
April 2020

Vaccination With Moderate Coverage Eradicates Oncogenic Human Papillomaviruses If a Gender-Neutral Strategy Is Applied.

Authors:
Simopekka Vänskä Tapio Luostarinen Iacopo Baussano Dan Apter Tiina Eriksson Kari Natunen Pekka Nieminen Jorma Paavonen Ville N Pimenoff Eero Pukkala Anna Söderlund-Strand Gary Dubin Geoff Garnett Joakim Dillner Matti Lehtinen

J Infect Dis 2020 Aug;222(6):948-956

Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.

View Article and Find Full Text PDF
August 2020

Peak neutralizing and cross-neutralizing antibody levels to human papillomavirus types 6/16/18/31/33/45/52/58 induced by bivalent and quadrivalent HPV vaccines.

Authors:
Filipe Colaço Mariz Noemi Bender Devasena Anantharaman Partha Basu Neerja Bhatla Madhavan Radhakrisna Pillai Priya R Prabhu Rengaswamy Sankaranarayanan Tiina Eriksson Michael Pawlita Kristina Prager Peter Sehr Tim Waterboer Martin Müller Matti Lehtinen

NPJ Vaccines 2020 14;5:14. Epub 2020 Feb 14.

2Infections and Cancer Epidemiology, Deutsches Krebsforschungszentrum (DKFZ), 69120 Heidelberg, Germany.

View Article and Find Full Text PDF
February 2020

Human papillomavirus genotype replacement: still too early to tell?

Authors:
Irene Man Simopekka Vänskä Matti Lehtinen Johannes A Bogaards

J Infect Dis 2020 Jan 27. Epub 2020 Jan 27.

Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.

View Article and Find Full Text PDF
January 2020

Safety of the AS04-adjuvanted human papillomavirus (HPV)-16/18 vaccine in adolescents aged 12-15 years: end-of-study results from a community-randomized study up to 6.5 years.

Authors:
Dan Bi Dan Apter Tiina Eriksson Mari Hokkanen Julia Zima Silvia Damaso Maaria Soila Gary Dubin Matti Lehtinen Frank Struyf

Hum Vaccin Immunother 2020 Jun 12;16(6):1392-1403. Epub 2019 Dec 12.

GSK , Wavre, Belgium.

View Article and Find Full Text PDF
June 2020

The Prevalence of HSV, HHV-6, HPV and in positive and Negative Urogenital Samples among Young Women in Finland.

Authors:
Suvi Korhonen Kati Hokynar Tiina Eriksson Kari Natunen Jorma Paavonen Matti Lehtinen Mirja Puolakkainen

Pathogens 2019 Dec 1;8(4). Epub 2019 Dec 1.

Department of Virology, University of Helsinki and Helsinki University Hospital, PO Box 21, FI-00014 Helsinki, Finland.

View Article and Find Full Text PDF
December 2019

Baseline findings and safety of infrequent vs. frequent screening of human papillomavirus vaccinated women.

Authors:
Karolina Louvanto Tiina Eriksson Penelope Gray Dan Apter Iacopo Baussano Anne Bly Katja Harjula Kaisa Heikkilä Mari Hokkanen Leila Huhtinen Marja Ikonen Heidi Karttunen Mervi Nummela Anna Söderlund-Strand Ulla Veivo Joakim Dillner Miriam Elfstöm Pekka Nieminen Matti Lehtinen

Int J Cancer 2020 Jul 16;147(2):440-447. Epub 2019 Dec 16.

Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.

View Article and Find Full Text PDF
July 2020

Effectiveness of the AS04-adjuvanted HPV-16/18 vaccine in reducing oropharyngeal HPV infections in young females-Results from a community-randomized trial.

Authors:
Matti Lehtinen Dan Apter Tiina Eriksson Katja Harjula Mari Hokkanen Tuomas Lehtinen Kari Natunen Silvia Damaso Maaria Soila Dan Bi Frank Struyf

Int J Cancer 2020 Jul 14;147(1):170-174. Epub 2019 Dec 14.

GSK, Wavre, Belgium.

View Article and Find Full Text PDF
July 2020

Is the risk of cervical atypia associated with the interval between menarche and the start of sexual activity? A population-based cohort study.

Authors:
Indira Adhikari Tiina Eriksson Tapio Luostarinen Dan Apter Matti Lehtinen

BMJ Open 2019 09 11;9(9):e030091. Epub 2019 Sep 11.

Department of Health Sciences, Tampere University, Tampere, Finland.

View Article and Find Full Text PDF
September 2019

Age-specific HPV type distribution in high-grade cervical disease in screened and unvaccinated women.

Authors:
Karoliina Aro Pekka Nieminen Karolina Louvanto Maija Jakobsson Seppo Virtanen Matti Lehtinen Joakim Dillner Ilkka Kalliala

Gynecol Oncol 2019 08 5;154(2):354-359. Epub 2019 Jun 5.

Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Haartmaninkatu 2, 00290 Helsinki, Finland. Electronic address:

View Article and Find Full Text PDF
August 2019

Occurrence of human papillomavirus (HPV) type replacement by sexual risk-taking behaviour group: Post-hoc analysis of a community randomized clinical trial up to 9 years after vaccination (IV).

Authors:
Penelope Gray Tapio Luostarinen Simopekka Vänskä Tiina Eriksson Camilla Lagheden Irene Man Johanna Palmroth Ville N Pimenoff Anna Söderlund-Strand Joakim Dillner Matti Lehtinen

Int J Cancer 2019 08 28;145(3):785-796. Epub 2019 Feb 28.

Faculty of Social Sciences, Tampere University, Tampere, Finland.

View Article and Find Full Text PDF
August 2019

Fast approximate computation of cervical cancer screening outcomes by a deterministic multiple-type HPV progression model.

Authors:
Simopekka Vänskä Johannes A Bogaards Kari Auranen Matti Lehtinen Johannes Berkhof

Math Biosci 2019 03 16;309:92-106. Epub 2019 Jan 16.

Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands.

View Article and Find Full Text PDF
March 2019

Eradication of human papillomavirus and elimination of HPV-related diseases - scientific basis for global public health policies.

Authors:
Matti Lehtinen Iacopo Baussano Jorma Paavonen Simopekka Vänskä Joakim Dillner

Expert Rev Vaccines 2019 02 7;18(2):153-160. Epub 2019 Feb 7.

a Department of Laboratory Medicine , Karolinska Institute , Stockholm , Sweden.

View Article and Find Full Text PDF
February 2019

Long-term Antibody Response to Human Papillomavirus Vaccines: Up to 12 Years of Follow-up in the Finnish Maternity Cohort.

Authors:
Hanna Artemchuk Tiina Eriksson Mario Poljak Heljä-Marja Surcel Joakim Dillner Matti Lehtinen Helena Faust

J Infect Dis 2019 01;219(4):582-589

Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.

View Article and Find Full Text PDF
January 2019